Oric Pharmaceuticals Inc (ORIC)

02:47 AM

What drives ORIC Pharmaceuticals Inc. stock priceExtraordinary performance - Autocar Professional

02:47 AM

11:40 AM

What analysts say about ORIC Pharmaceuticals Inc. stockFree Capital Allocation Plans - Autocar Professional

11:40 AM

07:28 AM

Is ORIC Pharmaceuticals Inc. a good long term investmentFree Trading Psychology Coaching - jammulinksnews.com

07:28 AM

Jul 20, 2025

ORIC Pharmaceuticals Inc. Stock Analysis and ForecastFree Investment Community - printweek.in

Jul 20, 2025

Jul 18, 2025

How high can ORIC Pharmaceuticals Inc. stock price go in 2025Massive Gain Ideas - Newser

Jul 18, 2025

Jul 17, 2025

ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 17, 2025

Jul 16, 2025

Why ORIC Pharmaceuticals Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser

Jul 16, 2025

Jul 15, 2025

What makes ORIC Pharmaceuticals Inc. stock price move sharplySmart High Yield Swing Trades - Newser

Jul 15, 2025

Jul 15, 2025

How ORIC Pharmaceuticals Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025

Jul 15, 2025

Oric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance

Jul 15, 2025

Jul 14, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 4.9%Should You Sell? - MarketBeat

Jul 14, 2025

Jul 11, 2025

Oric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 11, 2025

Jul 11, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated by Analysts at LADENBURG THALM/SH SH - MarketBeat

Jul 11, 2025

Jul 11, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Research Coverage Started at LADENBURG THALM/SH SH - Defense World

Jul 11, 2025

Jul 09, 2025

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $19.17 Consensus Price Target from Analysts - MarketBeat

Jul 09, 2025

Jul 08, 2025

ORIC: New Coverage Initiated with a Buy Rating and $15 Price Tar - GuruFocus

Jul 08, 2025

Jul 08, 2025

Ladenburg Thalmann initiates ORIC Pharmaceuticals stock with Buy rating By Investing.com - Investing.com UK

Jul 08, 2025

Jul 06, 2025

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 06, 2025

Jul 05, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Trading 10% HigherWhat's Next? - MarketBeat

Jul 05, 2025

Jul 03, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 03, 2025

Jul 03, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News - GuruFocus

Jul 03, 2025

Jul 03, 2025

ORIC Pharmaceuticals Awards 9,000 Stock Options Plus RSUs in Strategic New Hire Package - Stock Titan

Jul 03, 2025

Jun 27, 2025

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 1,034 Shares - MarketBeat

Jun 27, 2025

Jun 26, 2025

Trading (ORIC) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 26, 2025

Jun 26, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Trading 6.2% Higher After Insider Buying Activity - MarketBeat

Jun 26, 2025

Jun 25, 2025

Is Oric Pharmaceuticals, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025

Jun 24, 2025

Hedge Fund and Insider Trading News: Bill Ackman, Philippe Laffont, Soros Fund Management, Three Arrows Capital, Balyasny Asset Management, Millennium Management, Oric Pharmaceuticals Inc (ORIC), NVIDIA Corp (NVDA), and More - Insider Monkey

Jun 24, 2025

Jun 24, 2025

Oric Pharmaceuticals’ (ORIC) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Jun 24, 2025

Jun 23, 2025

Oric Pharmaceuticals director You Angie buys $262,898 in stock - Investing.com

Jun 23, 2025

Jun 19, 2025

All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy - Yahoo Finance

Jun 19, 2025

Jun 18, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Trading Down 3.4%Here's Why - MarketBeat

Jun 18, 2025